Money and Medicine The rationale for ERP is straightforward — to ensure that the maximum price paid for a drug is not excessive relative to its price in comparable countries. (Photo: Shutterstock)

External reference pricing that ties U.S. prescription drug costs to those in other countries may save money in the short term, but these savings would be difficult to sustain. The Commonwealth Fund reviewed published literature and technical reports to determine the viability of external reference pricing, or ERP.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.